Nasdaq ETFs

Economies abroad and within the U.S. are continuing to miss forecasts to increasingly larger degrees in moves that have investors concerned. The  spread of the delta variant and poorer-than-anticipated economic numbers, combined with signals that the Fed may be withdrawing economic supports soon, are all having a dampening effect on what has until recently been [...] Read more at ETFtrends.com.

Key Takeaways Capital Group, one of the largest managers of active mutual funds in the U.S., has filed paperwork to launch its first ETFs, with plans to launch six products in the first quarter of 2022. The pending ETFs will be fully transparent each day, unlike some recently launched products from Capital Group’s peers that [...] Read more at ETFtrends.com.

Solar energy is a vital component in the push toward renewable energy—a win-win for the Global X Renewable Energy Producers ETF (RNRG). Solar power was once an option that was exclusively available for the well-to-do. Nowadays, solar costs are dropping, making the technology more accessible for more individuals. Furthermore, the federal government’s green agenda is [...] Read more at ETFtrends.com.

Major smartphone company Huawei, hurting from continued U.S. sanctions, has fallen by the wayside, and a new Chinese tech company is profiting in its stead. Xiaomi Corp has swept through global markets, selling the most phones worldwide in June, and looks to continue its upward movement. Xiaomi has stepped into the gap after repeated sanctions [...] Read more at ETFtrends.com.

Mid cap equities can give investors a healthy median between large caps and small caps. Further still, investment gains in the Direxion Daily Mid Cap Bull 3X Shares (MIDU) have been anything but middling. The fund is up almost 50% year-to-date and has grown 150% within the past year. While MIDU and other leveraged funds are ideal [...] Read more at ETFtrends.com.

The healthcare sector is getting its groove back, as a variety of exchange traded funds dedicated to the group are printing or residing near new highs. The Invesco Dynamic Pharmaceuticals ETF (NYSEArca: PJP) is part of that group and closed just 2% below its all-time high last Friday. The $447 million PJP may be well-suited [...] Read more at ETFtrends.com.

By Solomon G. Teller, CFA, Chief Investment Strategist, Green Harvest Asset Management We’ve recently discussed some of the advantages of using ETFs to capture tax benefits here, here, and here. In addition, last week’s market activity highlighted another feature: the ability to capture tax benefits for the same account repeatedly through different ETFs. Last week, Green [...] Read more at ETFtrends.com.

By Kevin Nicholson, CFA, Global Fixed Income Co-CIO, Co-Head of Investment Committee SUMMARY We believe Jackson Hole may serve as the two-minute warning for the Fed to announce the tapering its Quantitative Easing (QE) purchases. The US has a supply issue and not a demand issue, and just needs time for them to balance out, [...] Read more at ETFtrends.com.

Cloud computing stocks and the related exchange traded funds are not as hot this year as they were in 2020, but that doesn’t mean investors should be dismissive of the group. In fact, in a case of “look now,” the WisdomTree Cloud Computing Fund (WCLD) is higher by more than 19% over the past 90 [...] Read more at ETFtrends.com.

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, AES Corp (Symbol: AES) has taken over the #1 spot from Autodesk Inc (Symbol: ADSK), according to ETF Channel. Below is a chart of AES Corp versus Autodesk Inc plott

A study of analyst recommendations at the major brokerages shows that Johnson & Johnson (Symbol: JNJ) is the #8 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel. Johnson & Johnson also comes in above the

The global ETF market hit $9 trillion in July — its highest level to date and triple that of just five years ago. With the market expected to grow by as much as 25% annually, there is a huge opportunity for asset managers who can succeed at both scale and scope. To date, J.P. Morgan [...] Read more at ETFtrends.com.

Make no mistake about it: the S&P 500 is not a well-balanced portfolio.  You hear it all the time, the S&P 500 is a passive index. In other words, there is no actively managed component to it. It does not diversify, reallocate, or rebalance, but that’s not to say that the S&P 500 is stagnant. [...] Read more at ETFtrends.com.

The FDA has officially given full approval to Pfizer and BioNTech for their COVID-19 vaccine, potentially making way for more approvals and more vaccine mandates, reports CNBC. It is a move that officials are hoping will encourage those who have been reluctant to receive a vaccine to get vaccinated. The federal approval was a first [...] Read more at ETFtrends.com.

In trading on Tuesday, shares of the First Trust Senior Loan Fund ETF (Symbol: FTSL) crossed below their 200 day moving average of $47.80, changing hands as low as $47.75 per share. First Trust Senior Loan Fund shares are currently trading off about 0.1% on the day. The chart

In recent trading, shares of Intellia Therapeutics Inc (Symbol: NTLA) have crossed above the average analyst 12-month target price of $155.00, changing hands for $158.07/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downg

In recent trading, shares of ONEOK Inc (Symbol: OKE) have crossed above the average analyst 12-month target price of $51.90, changing hands for $51.98/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation,

In recent trading, shares of Monte Rosa Therapeutics Inc (Symbol: GLUE) have crossed above the average analyst 12-month target price of $36.00, changing hands for $36.94/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downg

In recent trading, shares of Nordstrom, Inc. (Symbol: JWN) have crossed above the average analyst 12-month target price of $35.15, changing hands for $36.67/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valua

In recent trading, shares of Maxim Integrated Products, Inc. (Symbol: MXIM) have crossed above the average analyst 12-month target price of $103.80, changing hands for $106.63/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: